期刊文献+

培美曲塞二钠的合成研究进展 被引量:5

Advances in Synthesis of Pemetrexed Disodium
下载PDF
导出
摘要 介绍了合成新型抗癌药物培美曲塞二钠的两种方法。一种是以对溴苯甲酸为起始原料经酯化、缩合、溴代、环合、成盐等反应合成目标化合物,总收率达13.9%。另一是对碘苯甲酸甲酯与3-丁烯醇反应后溴代得4-(3-溴-4-氧代丁基)苯甲酸甲酯,与2,4-二氨基-6-羟基嘧啶反应后,再经水解得重要中间体2-氨基-4-氧代-5-[2-(4-羧基苯基)乙基]-4,7-二氢-3H-吡咯并(2,3-d)嘧啶,最后与L-谷氨酸二乙酯盐酸盐酰化、水解得培美曲塞二钠,总收率为16%。 There are two methods which to synthesize pemetrexed disodium, a novel anti-cancerogenic drug. Pemetrexed disodium was prepared via esterification, condensation, bromination, cyclization reaction and so on. The overall yield was 13.9%. The other method is Pemetrexed that was synthesized from methyl 4-iodobenzoate to afford 4-(4-oxobutyl)benzoic acid methyl ester, which was subjected to bromination with isopropylidene dibromomalonate, and subsequent to cyclization with 2,4-diamino-6-hydroxyprimidine, hydrolysis to give 2-amino-4, 7-dihydro-4-oxo-5-[2-(4-carboxyphenyl)ethyl]-i H-pyrro- lo(2,3-d)pyrimidine, followed by condensation with L-glutamic acid diester, and hydrolysis to give pemetrexed disodium in an overall yield 16%.
出处 《河北化工》 2009年第5期5-6,21,共3页 Hebei Chemical Industry
关键词 培美曲塞二钠 抗肿瘤药 化学合成 pemetrexed disodium anticancer agent chemical synthesis
  • 相关文献

参考文献9

  • 1王晓光,李金瀚,罗荣城.培美曲塞治疗非小细胞肺癌临床研究进展[J].中国肺癌杂志,2005,8(3):254-256. 被引量:16
  • 2Suwanrusme H,Meyer ML,Green MR.Pemetrexed alone and in combinationwith platinum compounds in the management of malignant mesothelioma[J].Clin Lung Cancer,2004,5(2):56-60.
  • 3Tracy G M,Castanet J.Pemetrexed disodium[J].Drugs Future,1998,23(5):498-507.
  • 4Barnett C J,Wilson TM.Process for preparing 5-substituted pyrrolo 2 (2,3-d) pyrimidines[P].EP:0 589 720,1994-03-30.
  • 5Kjell D P,Slattery B J,Barnett C J.Processes and inter-mediates useful to make antifolates[P].US:6 013 828,2000-01-11.
  • 6Taylor E C,Kuhnt D G,SH IH C.N2 (pyrrolo[2,3-d] pyrimi-din-3-ylacyl) -glutamic acid derivatives[P].EP:0 432 677,1991-06-19.
  • 7Taylor e c,Patel H H.Process for the p reparation of pyrrolo[2,3-d]pyrimidines[P].EP:0 549 886,1996-07-07.
  • 8Taylor E C,L iu B.Process for the p reparation of p yrroio[2,3-d]pyrimidines[P].WO:2 000 011 004 2000-03-02.
  • 9Barnett C J,Wilson T M Process for preparing 5-substituted Pyrrolo-[2,3-d]pyrimidines[P],EP:0 589 720,1994-03-30.

二级参考文献10

  • 1Adjei AA. Pharmacology and mechanism of action of pemetrexed. Clin Lung Cancer,2004,5 Suppl 2: S51-55.
  • 2Thodtmann R, Depenbrock H, Dumez H,et al. Clinical and pharmacokinetic phase Ⅰ study of multitargeted antifolate (LY231514) in combination with cisplatin. J Clin Oncol,1999,17(10): 3009-3016.
  • 3Vogelzang NJ, Rusthoven J J, Symanowski J, et al. Phase Ⅲ study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleuralmesothelioma. J Clin Oncol, 2003, 21(14): 2636-2644.
  • 4Smit EF, Mattson K, von Pawel J, et al.ALIMTA (pemetrexed disodium) as second-line treatment of non-small- cell lung cancer: a phase Ⅱ study. Ann Oncol,2003,14(3) :455-460.
  • 5Hanna N, Shepherd FA, Fossella FV, et al. Randomized phase Ⅲ trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously trea ted with chemotherapy. J Clin Oncol,2004,22(9) : 1589-1597.
  • 6Rusthoven J J, Eisenhauer E, Butts C, et al. Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase Ⅱ study. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol,1999,17(4) :1194.
  • 7Clarke SJ, Abratt R, Goedhals L, et al.Phase Ⅱ trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapynaive patients with advanced non-small-cell lung cancer. Ann Oncol, 2002, 13 (5) :737-741.
  • 8Manegold C, Gatzemeier U, von Pawel J,et al. Front-line treatment of advanced non-small-cell lung cancer with MTA (LY231514, pemetrexed disodium, ALIMTA) and cisplatin: a multicenter phase Ⅱ trial. Ann Oncol,2000,11(4) : 435-440.
  • 9Scagliotti GV. Pemetrexed plus carboplatin or oxaliplatin in advanced non-small cell lung cancer. Semin Oncol,2005,32(2 Suppl 2) :S5-S8.
  • 10Monnerat C, Le Chevalier T, Kelly K, et al. Phase Ⅱ study of pemetrexed-gemcitabine combination in patients with advanced-stage non-small cell lung cancer.Clin Cancer Res, 2004, 10 (16) : 5439-5446.

共引文献15

同被引文献57

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部